HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CCA's Shiara buy expands H&BA portfolio with five scents; Cloud Dance to debut in June.

This article was originally published in The Rose Sheet

Executive Summary

CCA's SHIARA PURCHASE EXPANDS H&BA PORTFOLIO WITH FRAGRANCES under a deal completed March 31, East Rutherford, N.J.-based CCA Industries announced. The acquisition includes manufacturing and distribution rights to Shiara Holdings' Cherry Vanilla, Mandarin Vanilla, Amber Musk and Sunset Cafe women's scents and the Vision fragrance for men, as well as existing inventory worth $1.5 mil. The CCA/Shiara deal does not include the NFL fragrance franchise, which was discontinued. The Shiara fragrance house generated $7 mil. in sales in 1997. CCA reported $38 mil. in revenues in its 1997 fiscal year (ended Nov. 30). Following the sale of the scents, Schaumburg, Ill.-based Shiara has ceased operations. In February, Shiara settled a trademark suit with Revlon under which the company agreed to stop using the Shiara name on fragrance packaging ("The Rose Sheet" Jan. 26, p. 15).

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005281

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel